F4 Pharma GmbH           


December 19, 2014:

• Paper about FX06 in 'The Lancet':

Doctor who survived Ebola received experimental drug treatment. More >>

• Bloomberg report:

Ebola Doctor’s Recovery Shows Promise of Resurrected Lung Drug. More >>

November 10, 2014:

F4 Pharma’s developmental drug FX06 successful in treating vascular leak in Ebola.
See press release >>

 
>> Enter >>


 

©2013 F4 Pharma GmbH i.G.  •  info@f4-pharma.com  •  Page last modified: 19.12.2014